MONTHLY INTELLIGENCE | UPCOMING EVENTS | MEDIA DIRECTORY | CONFERENCES

MONTHLY HEALTHCARE NEWSLETTER - APRIL 2020A GLOBAL LEADER IN STRATEGIC HEALTHCARE COMMUNICATIONSLondon | New York | Boston | San Francisco

VISIT WWWCONSILIUM-COMMSCOM FOR MORE INTEL

It has been an unprecedented past few weeks and the Consilium team has been as busy as ever helping clients communicate during the COVID-19 crisis Coronavirus has undoubtedly changed the way we all work and while itrsquos very true that we have missed face to face interactions with our clients and colleagues the Consilium team has quickly adapted to the ldquonew normalrdquo aided by the smart technology we now have at our disposal to stay connected In many ways embracing video conferencing and virtual meetings has been a great opportunity to get to see our clients and colleagues in a more informal setting ndash as you will see from some of the pictures below

Despite the disruption and the plethora of announcements we have advised on surrounding COVID-19 including delays to preliminary results COVID-19 impact statements and new AGM venues to name but a few we have seen some exceptional transactions from our clients cross the line These include some significant partnering and licensing deals with Oxford Biomedica signing a new Licence and Clinical Supply Agreement with Juno Therapeutics a Bristol-Myers Squibb company worth up to $227 million as well as potential additional royalties Silence Therapeutics signing a $400m collaboration with AstraZeneca to develop new

BUSINESS (NOT QUITE) AS USUAL CONSILIUMrsquoS LIFE IN LOCKDOWN

siRNA-based medicines and Sitryx securing an impressive $880 million drug development deal with Lilly to develop new immunometabolic medicines Fundraisings by our clients have continued including Synairgen which raised pound14m to progress its live COVID-19 clinical trial iTeos which raised a $125m Series B2 round 4BIO Capitalrsquos portfolio company Redpin which raised $15 million and miDiagnostics which raised euro14 million demonstrating that innovative companies can raise money even in these difficult market conditions We also welcomed the news by Gilde Healthcare in Europe which closed a new $450 million venture and growth capital fund and other US funds which have been announcing similar hefty new healthcare funds

These successful transactions and some of the work being undertaken by our clients in response to the COVID-19 crisis mobilising rapidly to investigate new therapies vaccines and rapid diagnostics remind us of some important truths First that our sector is resilient and will continue to function and innovate as we move through the crisis and second that for the time being at least cash remains king to companies and investors Letrsquos hope we are back to the ldquoold normalrdquo soon Thank you to all our clients for your support and to our Consilium teams in Europe and the US for your continued hard work and dedication

If you would like to receive our Monday Healthcare Bulletin which summarises all healthcare business news from the weekend please contact admincscconsilium-commscom

THIS MONTHrsquoS MOVERS AND SHAKERS

CONNAUGHT ROOMS WC2B19 NOVEMBER

If you would like to receive our Monday Healthcare Bulletin which summarises all healthcare business news from the weekend please contact

admincscconsilium-commscom

ndash Vectura Group appointed Mark Bridgewater as CCO

ndash Achilles Therapeutics appointed Professor Sergio Quezada as CSO and Carsten Boess as Non-Executive Director

ndash Redpin Therapeutics appointed Abhinav Shukla as CTOO

ndash Bone Therapeutics appoints Stefanos Theoharis as CBO

ndash Unity Biotechnology appointed Anirvan Ghosh as CEO

ndash Altavant Sciences appointed Howard Lazarus as CMO

ndash Theramex appointed Robert Stewart as CEO

ndash AB2 Bio appointed Michael Soldan as CEO

ndash Senti Biosciences appointed Jose Iglesias as CMO

ndash Oculis SA appointed Marcia de Souza Lima as CMO

ndash WindMIL Therapeutics appointed Patrick Fabbio as CFO

ndash Celyad appointed Stephen Rubino as CBO ndash Prothena appointed Brandon Smith as CBO

ndash Fujifilm Diosynth Biotechnologies appointed Martin Meeson as CEO

ndash Adaptate Biotherapeutics appointed Mihriban Tuna as CSO

ndash E-Scape Bio appointed Paul Wren as CSO

ndash CureVac appointed Ingmar Hoerr as CEO

ndash Epizyme appointed Jeffery Kutok as CSO

CONSILIUM STAFFS CHARITY INITIATIVES

Consilium is delighted to support Fuel Our Frontline ndash a great initiative launched to help deliver food direct to NHS workers that are on the front line in the battle against COVID-19 With the help of generous donations from the public to the lsquoFuel Our Frontlinersquo crowd funding page the team has delivered food packages to a number of hospitals

ndash Morphic Therapeutic appointed Peter Linde as CMO

ndash RubrYc Therapeutics appointed Ramesh Baliga as CSO

ndash Thrive Earlier Detection appointed Matt Franklin as CMO

ndash Recursion appointed Shafique Virani as Chief Corporate Development Officer

ndash Urovant Sciences appointed Jim Robinson as CEO

ndash Viracta Therapeutics appointed Lisa Rojkjaer as CMO

ndash Epizyme appointed Jeffery Kutok as CSO

ndash Qiagen appointed Thierry Bernard as CEO

ndash Recursion appointed Michael Secora as CFO

ndash KBP Biosciences appointed Nick Hart as CFO

ndash EpimAb Biotherapeutics appointed Xinyi ldquoDavidrdquo Gu as CFO

ndash Medica Group appointed Richard Jones as CFO

ndash Sutura Therapeutics appointed Mark Beards as CEO

ndash e-therapeutics appointed Laura Roca-Alonso as CBO

ndash Pfizer appointed Susan Desmond-Hellmann to its Board of Directors

ndash ObsEva appointed Fabien de Ladonchamps as CFO

ndash Arix Biosciences appointed Naseem Amin as Executive Chairman

MONTHLY INTELLIGENCE

ndash Helen Albert has left Labiotech and is now working as a freelance journalist

ANALYST AND SPECIALIST SALES MOVES ndash Fowey Harvey joined Liberum as Healthcare Analyst

ndash Khaled Habayeb joined Barclays Life Science Equity Capital Markets Group

ndash Luisa Hector and Kerry Holford joined the healthcare team at Berenberg as equity research analysts

ndash James Mainwaring has left Stifel

MEDIA MOVES ndash Carlo Martuscelli has joined Politico as Healthcare Reporter

ndash Mike Ward has left Informa ndash Peter Evans has now become Senior Business Correspondent for the Sunday Times

ndash Liam Kelly has now become Enterprise Correspondent for The Sunday Times

ndash Smitha Mundasad has returned to BBC News as Health Reporter following her maternity leave

HIGHLIGHTED FUNDRAISING ACTIVITY FROM MARCH TO APRIL 2020

COMPANY NAME AMOUNT TYPE OF COUNTRY DATE

PUBLIC COMPANY FINANCINGS

DermTech $65 million Private Placement US 3-Mar-20

Zogenix $2002 million Follow-on US 5-Mar-20

Karyopharm Therapeutics $150 million Follow-on US 5-Mar-20

BridgeBio Pharma $475 million Private Offering US 5-Mar-20

Kala Pharmaceuticals $1262 million Follow-on US 11-Mar-20

LifeSci Acquisition $60 million Upsized IPO US 11-Mar-20

Imara $752 million IPO US 13-Mar-20

Synairgen pound140 million Follow-on UK 26-Mar-20

PRIVATE COMPANY FINANCINGS

Xilio Therapeutics $1005 million Series B US 2-Mar-20

Pliant Therapeutics $100 million Series C US 3-Mar-20

Akouos $105 million Series B US 3-Mar-20

Element Science $1456 million Series C US 3-Mar-20

CICC Capital $2274 million Fund close China 3-Mar-20

Kahr Medical $18 million Private Round Israel 3-Mar-20

Primmune Therapeutics $7 million Seed Funding US 3-Mar-20

Scipio bioscience euro6 million Series A France 3-Mar-20

Amunix Pharmaceuticals $73 million Series A US 4-Mar-20

Cinclus Pharma AG $263 million Private Round Sweden 5-Mar-20

Culture Biosciences $15 million Series A US 5-Mar-20

GenFleet $50 million Series B China 9-Mar-20

Numab Therapeutics $22 million Series B Switzerland 9-Mar-20

Arkin Holdings $140 million Fund close Israel 11-Mar-20

Silverback Therapeutics $785 million Series B US 11-Mar-20

BioSight $19 million Series C Israel 11-Mar-20

BillionToOne $15 million Series A US 11-Mar-20

Harbour BioMed $75 million Series B US 12-Mar-20

Nurix Therapeutics $120 million Private Round US 12-Mar-20

Sigilon Therapeutics $803 million Series B US 17-Mar-20

Tempus $100 million Series G US 17-Mar-20

Circle Pharma $45 million Series B US 17-Mar-20

Exuma Biotech $19 million Series B US 17-Mar-20

Design Therapeutics $45 million Series A US 21-Mar-20

Apexigen $123 million Series C US 24-Mar-20

Asieris Pharmaceuticals undisclosed Series C China 24-Mar-20

FampS Pharmatech Undisclosed Series B China 24-Mar-20

Abbisko Therapeutics $70 million Series C US 25-Mar-20

IASO Biotherapeutics $60 million Series B China 25-Mar-20

Regenacy Pharmaceuticals $30 million Series A US 25-Mar-20

Redpin Therapeutics $155 million Series A US 25-Mar-20

miDiagnostics euro14 million Private Round Belgium 26-Mar-20

ElevateBio $170 million Series B UK 30-Mar-20

iTeos $125 million Series B2 USBelgium 1-Apr-20

Flagship Pioneering $11 billion Fund Close US 2-Apr-20

Source BioCentury

INVESTOR CONFERENCE EVENT CALENDAR

2020

You can view the full 2020 investor conference event calendar here

APRILBioCentury Future Leaders in the Biotech Industry New York (Cancelled) ARM Cell amp Gene Meeting on the Mediterranean Barcelona (Cancelled) Kempen amp Co Life Sciences Conference Amsterdam (Cancelled) BioTrinity 2020 London (28-29 April) - NOW A DIGITAL EVENT

MAY ChinaBio Partnering Forum Suzhou (Cancelled) BioEquity Europe Barcelona (Cancelled) Citi Swiss Healthcare Day Zurich (7 May) - NOW A DIGITAL EVENT

JUNEJefferies Healthcare Conference London (2-4 June) Goldman Sachs 40th Annual Global Healthcare Conference Palos Verdes (9-11 June) Citi 8th Annual European Healthcare Conference London (16-17 June) Preparing for Prime Time Best Practice Workshop for UK Issuers Considering Access to the US Markets London (POSTPONED) Piper Jaffray Heartland Summit Minneapolis (17-18 June) Next Generation CAR amp T Cell Therapies San Francisco (22-24 June) Bryan Garnier amp Co Annual Oncology Day Paris (24-25 June) JP Morgan European Healthcare Conference London (Cancelled)

JULYBiotech CEO Summit Napa Napa (12-15 July)

AUGUSTCanaccord Genuity Annual Growth Conference Boston (12-13 August)

SEPTEMBERRW Baird Healthcare Conference New York (4-5 September)Wells Fargo Securities Healthcare Conference Boston (5-6 September)Citi 15th Annual BioPharma Conference Boston (9-10 September)Goldman Sachs Annual Biotech Symposium London (11 September)Morgan Stanley Global Healthcare Conference New York (14-16 September) CAR-TCR Summit Boston 2020 Boston (14-17 September) Cantor Global Healthcare Conference New York (15-17 September)Cell amp Gene Therapy Manufacturing and Commercialization Boston (21-24 September)Boston Biotech Week Boston (21-24 September)Boston BioTech BD Conference Boston (22 September) Annual HealthTech Investment Forum Basel (22 September)Sachs 20th Annual Biotech in Europe Forum Basel (23-24 September) Ladenburg Thalman Healthcare Conference New York (26 September)BAML Global Healthcare Conference London (TBD) Rodman amp Renshaw Annual Global Investment Conference New York (TBD)BioCentury Annual Newsmakers in the Biotech Industry New York (TBD)

OCTOBERLSX World Congress USA Boston (7 October)BIO Investor Forum 2020 San Francisco (13-14 October)ARM Cell amp Gene meeting on the Mesa Carlsbad (14-16 October)BIO-Europe 2020 Hamburg (26-28 October)BIA UK Bioscience Forum London (TBD)Cowen amp Co Annual Therapeutics Conference New York (TBD)

NOVEMBERFT Global Pharmaceutical and Biotechnology Conference London (9-10 November)Credit Suisse Annual Healthcare Conference Scottsdale (9-11 November)Consilium Strategic Communications Annual Healthcare Conference London (16 November)Inveuro$tival Showcase London (16 November)Jefferies Annual Healthcare Conference London (17-19 November)Bryan Garnier amp Co 2020 Healthcare Conference Paris (TBD)

COVID-19 updateThe Awards Ceremony has been re-scheduled from Thursday 11 June 2020 to Tuesday 10

November 2020

INVESTOR CONFERENCE EVENT CALENDAR

2020

You can view the full 2020 investor conference event calendar here

APRILBioCentury Future Leaders in the Biotech Industry New York (Cancelled) ARM Cell amp Gene Meeting on the Mediterranean Barcelona (Cancelled) Kempen amp Co Life Sciences Conference Amsterdam (Cancelled) BioTrinity 2020 London (28-29 April) - NOW A DIGITAL EVENT

MAY ChinaBio Partnering Forum Suzhou (Cancelled) BioEquity Europe Barcelona (Cancelled) Citi Swiss Healthcare Day Zurich (7 May) - NOW A DIGITAL EVENT

JUNEJefferies Healthcare Conference London (2-4 June) Goldman Sachs 40th Annual Global Healthcare Conference Palos Verdes (9-11 June) Citi 8th Annual European Healthcare Conference London (16-17 June) Preparing for Prime Time Best Practice Workshop for UK Issuers Considering Access to the US Markets London (POSTPONED) Piper Jaffray Heartland Summit Minneapolis (17-18 June) Next Generation CAR amp T Cell Therapies San Francisco (22-24 June) Bryan Garnier amp Co Annual Oncology Day Paris (24-25 June) JP Morgan European Healthcare Conference London (Cancelled)

JULYBiotech CEO Summit Napa Napa (12-15 July)

AUGUSTCanaccord Genuity Annual Growth Conference Boston (12-13 August)

SEPTEMBERRW Baird Healthcare Conference New York (4-5 September)Wells Fargo Securities Healthcare Conference Boston (5-6 September)Citi 15th Annual BioPharma Conference Boston (9-10 September)Goldman Sachs Annual Biotech Symposium London (11 September)Morgan Stanley Global Healthcare Conference New York (14-16 September) CAR-TCR Summit Boston 2020 Boston (14-17 September) Cantor Global Healthcare Conference New York (15-17 September)Cell amp Gene Therapy Manufacturing and Commercialization Boston (21-24 September)Boston Biotech Week Boston (21-24 September)Boston BioTech BD Conference Boston (22 September) Annual HealthTech Investment Forum Basel (22 September)Sachs 20th Annual Biotech in Europe Forum Basel (23-24 September) Ladenburg Thalman Healthcare Conference New York (26 September)BAML Global Healthcare Conference London (TBD) Rodman amp Renshaw Annual Global Investment Conference New York (TBD)BioCentury Annual Newsmakers in the Biotech Industry New York (TBD)

OCTOBERLSX World Congress USA Boston (7 October)BIO Investor Forum 2020 San Francisco (13-14 October)ARM Cell amp Gene meeting on the Mesa Carlsbad (14-16 October)BIO-Europe 2020 Hamburg (26-28 October)BIA UK Bioscience Forum London (TBD)Cowen amp Co Annual Therapeutics Conference New York (TBD)

NOVEMBERFT Global Pharmaceutical and Biotechnology Conference London (9-10 November)Credit Suisse Annual Healthcare Conference Scottsdale (9-11 November)Consilium Strategic Communications Annual Healthcare Conference London (16 November)Inveuro$tival Showcase London (16 November)Jefferies Annual Healthcare Conference London (17-19 November)Bryan Garnier amp Co 2020 Healthcare Conference Paris (TBD)

COVID-19 updateThe Awards Ceremony has been re-scheduled from Thursday 11 June 2020 to Tuesday 10

November 2020

CONSILIUM STRATEGIC COMMUNICATIONSINTERNATIONAL HEALTHCARE COMMUNICATIONS

Leading international strategic PR and IR advisor

focused on healthcare

Trusted long-term relationships with clients

Boards and advisors

Networked across all critical stakeholders

Europersquos largest specialist team with deep sector

knowledge

Experts across all sub-sectors

of healthcare

41 LOTHBURY | LONDON | EC2R 7HG NEW YORK | BOSTON | SAN FRANCISCO

+44 (0)20 3709 5700 infoconsilium-commscom wwwconsilium-commscom

ConsiliumHC

19 November Connaught Rooms WC2B

CONSILIUM IS PROUD TO BE A MEMBER OF